Daniel Naumovas
Daniel Naumovas publishes mostly in Infectious Diseases, Immunology and Public Health, Environmental and Occupational Health, on topics such as SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Zoonotic diseases and public health.
- World rank
- #1,824,136 of 7,710,434 ranked researchers
- Rank in Lithuania
- #519 of 9,273
- Works
- 20
- Citations
- 430
- Citations per work
- 21.5
What does Daniel Naumovas research?
Daniel Naumovas's work is mostly in Medicine (58%), Immunology and Microbiology (13%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1258.3%
- Medicine1258.3%
- Everything else421.7%
- Life Sciences420.0%
- 1Infectious Diseases38% of their works
- 2Immunology13% of their works
- 3Public Health, Environmental and Occupational Health10% of their works
- 4Molecular Biology7% of their works
- 5Oncology7% of their works
- 6Neurology3% of their works
Research topics
Which keywords describe Daniel Naumovas's research?
The keywords of their largest research topics: SARS-CoV-2, ACE2 Receptor, Pandemic, Immunity, Coronavirus, Vaccine, Clinical Characteristics and Epidemiology.
- Trained Immunity
- Natural Killer Cells
- Innate Memory
- Diagnostics
- Cancer Immunotherapy
- Zoonotic Diseases
- Epidemiology
- Vaccine
- Immunity
- ACE2 Receptor
- SARS-CoV-2
- Pandemic
- Coronavirus
- Clinical Characteristics
- One Health
- COVID-19
- Dendritic Cells
- Foxp3
- NK Cell Recognition
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- SARS-CoV-2223 topics
- ACE2 Receptor202 topics
- Pandemic202 topics
- Immunity152 topics
- Coronavirus131 topic
- Vaccine131 topic
- Clinical Characteristics71 topic
- Epidemiology71 topic
- One Health31 topic
- Zoonotic Diseases31 topic
- COVID-1921 topic
- Cancer Immunotherapy21 topic
- Dendritic Cells21 topic
- Diagnostics21 topic
- Foxp321 topic
- Innate Memory21 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
- TGF-ß21 topic
- Trained Immunity21 topic
Where does Daniel Naumovas work?
Daniel Naumovas's main affiliation in the publication record is Vilnius University, Lithuania.
How many publications and citations does Daniel Naumovas have?
OpenAlex counts 20 works and 430 citations for Daniel Naumovas, an h-index of 7, ranking #1,824,136 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel Naumovas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.